Titre : Thérapie comportementale

Thérapie comportementale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Visual Field Tests
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Thérapie comportementale : Questions médicales les plus fréquentes", "headline": "Thérapie comportementale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Thérapie comportementale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-14", "dateModified": "2025-03-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Thérapie comportementale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Psychothérapie", "url": "https://questionsmedicales.fr/mesh/D011613", "about": { "@type": "MedicalCondition", "name": "Psychothérapie", "code": { "@type": "MedicalCode", "code": "D011613", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thérapie de maitrise de la colère", "alternateName": "Anger Management Therapy", "url": "https://questionsmedicales.fr/mesh/D000067449", "about": { "@type": "MedicalCondition", "name": "Thérapie de maitrise de la colère", "code": { "@type": "MedicalCode", "code": "D000067449", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.087" } } }, { "@type": "MedicalWebPage", "name": "Analyse comportementale appliquée", "alternateName": "Applied Behavior Analysis", "url": "https://questionsmedicales.fr/mesh/D000072357", "about": { "@type": "MedicalCondition", "name": "Analyse comportementale appliquée", "code": { "@type": "MedicalCode", "code": "D000072357", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.131" } } }, { "@type": "MedicalWebPage", "name": "Thérapie aversive", "alternateName": "Aversive Therapy", "url": "https://questionsmedicales.fr/mesh/D001348", "about": { "@type": "MedicalCondition", "name": "Thérapie aversive", "code": { "@type": "MedicalCode", "code": "D001348", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.174" } } }, { "@type": "MedicalWebPage", "name": "Thérapie cognitive", "alternateName": "Cognitive Behavioral Therapy", "url": "https://questionsmedicales.fr/mesh/D015928", "about": { "@type": "MedicalCondition", "name": "Thérapie cognitive", "code": { "@type": "MedicalCode", "code": "D015928", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.350" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thérapie d'acceptation et d'engagement", "alternateName": "Acceptance and Commitment Therapy", "url": "https://questionsmedicales.fr/mesh/D064869", "about": { "@type": "MedicalCondition", "name": "Thérapie d'acceptation et d'engagement", "code": { "@type": "MedicalCode", "code": "D064869", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.350.249" } } }, { "@type": "MedicalWebPage", "name": "Restructuration cognitive", "alternateName": "Cognitive Restructuring", "url": "https://questionsmedicales.fr/mesh/D000088686", "about": { "@type": "MedicalCondition", "name": "Restructuration cognitive", "code": { "@type": "MedicalCode", "code": "D000088686", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.350.375" } } }, { "@type": "MedicalWebPage", "name": "Pleine conscience", "alternateName": "Mindfulness", "url": "https://questionsmedicales.fr/mesh/D064866", "about": { "@type": "MedicalCondition", "name": "Pleine conscience", "code": { "@type": "MedicalCode", "code": "D064866", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.350.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Remédiation cognitive", "alternateName": "Cognitive Remediation", "url": "https://questionsmedicales.fr/mesh/D000072466", "about": { "@type": "MedicalCondition", "name": "Remédiation cognitive", "code": { "@type": "MedicalCode", "code": "D000072466", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.365" } } }, { "@type": "MedicalWebPage", "name": "Désensibilisation psychologique", "alternateName": "Desensitization, Psychologic", "url": "https://questionsmedicales.fr/mesh/D003887", "about": { "@type": "MedicalCondition", "name": "Désensibilisation psychologique", "code": { "@type": "MedicalCode", "code": "D003887", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.506" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Désensibilisation et reprogrammation par mouvements oculaires", "alternateName": "Eye Movement Desensitization Reprocessing", "url": "https://questionsmedicales.fr/mesh/D057169", "about": { "@type": "MedicalCondition", "name": "Désensibilisation et reprogrammation par mouvements oculaires", "code": { "@type": "MedicalCode", "code": "D057169", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.506.162" } } }, { "@type": "MedicalWebPage", "name": "Thérapie implosive", "alternateName": "Implosive Therapy", "url": "https://questionsmedicales.fr/mesh/D007171", "about": { "@type": "MedicalCondition", "name": "Thérapie implosive", "code": { "@type": "MedicalCode", "code": "D007171", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.506.325" } } }, { "@type": "MedicalWebPage", "name": "Thérapie par réalité virtuelle", "alternateName": "Virtual Reality Exposure Therapy", "url": "https://questionsmedicales.fr/mesh/D063367", "about": { "@type": "MedicalCondition", "name": "Thérapie par réalité virtuelle", "code": { "@type": "MedicalCode", "code": "D063367", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.506.662" } } } ] }, { "@type": "MedicalWebPage", "name": "Thérapie comportementale dialectique", "alternateName": "Dialectical Behavior Therapy", "url": "https://questionsmedicales.fr/mesh/D000077252", "about": { "@type": "MedicalCondition", "name": "Thérapie comportementale dialectique", "code": { "@type": "MedicalCode", "code": "D000077252", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.628" } } }, { "@type": "MedicalWebPage", "name": "Thérapie par la relaxation", "alternateName": "Relaxation Therapy", "url": "https://questionsmedicales.fr/mesh/D012064", "about": { "@type": "MedicalCondition", "name": "Thérapie par la relaxation", "code": { "@type": "MedicalCode", "code": "D012064", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Méditation", "alternateName": "Meditation", "url": "https://questionsmedicales.fr/mesh/D019122", "about": { "@type": "MedicalCondition", "name": "Méditation", "code": { "@type": "MedicalCode", "code": "D019122", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.750.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Chronothérapie sur les phases de sommeil", "alternateName": "Sleep Phase Chronotherapy", "url": "https://questionsmedicales.fr/mesh/D055865", "about": { "@type": "MedicalCondition", "name": "Chronothérapie sur les phases de sommeil", "code": { "@type": "MedicalCode", "code": "D055865", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Thérapie comportementale", "alternateName": "Behavior Therapy", "code": { "@type": "MedicalCode", "code": "D001521", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Daniel F Gros", "url": "https://questionsmedicales.fr/author/Daniel%20F%20Gros", "affiliation": { "@type": "Organization", "name": "Mental Health Service, Ralph H. Johnson VA Healthcare System, Charleston, South Carolina, USA." } }, { "@type": "Person", "name": "Tanja van der Zweerde", "url": "https://questionsmedicales.fr/author/Tanja%20van%20der%20Zweerde", "affiliation": { "@type": "Organization", "name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands. Electronic address: t.vander.zweerde@vu.nl." } }, { "@type": "Person", "name": "Jaap Lancee", "url": "https://questionsmedicales.fr/author/Jaap%20Lancee", "affiliation": { "@type": "Organization", "name": "Department of Clinical Psychology, University of Amsterdam, Nieuwe Achtergracht 129, Amsterdam 1018 WS, the Netherlands; PsyQ Amsterdam, Amsterdam, the Netherlands." } }, { "@type": "Person", "name": "Annemieke van Straten", "url": "https://questionsmedicales.fr/author/Annemieke%20van%20Straten", "affiliation": { "@type": "Organization", "name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands." } }, { "@type": "Person", "name": "Shireen L Rizvi", "url": "https://questionsmedicales.fr/author/Shireen%20L%20Rizvi", "affiliation": { "@type": "Organization", "name": "Rutgers University. Electronic address: slrizvi@gsapp.rutgers.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "[The ground visual field assessment, using two methods, compared with Goldmann perimetry].", "datePublished": "2022-07-05", "url": "https://questionsmedicales.fr/article/35798620", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jfo.2022.03.018" } }, { "@type": "ScholarlyArticle", "name": "Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma.", "datePublished": "2023-05-10", "url": "https://questionsmedicales.fr/article/37171991", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/IJG.0000000000002236" } }, { "@type": "ScholarlyArticle", "name": "Visual field progression in open-angle glaucoma after refractive corneal ablation surgery.", "datePublished": "2023-01-30", "url": "https://questionsmedicales.fr/article/36715786", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10103-023-03709-1" } }, { "@type": "ScholarlyArticle", "name": "Risk factors for visual field progression in newly diagnosed exfoliation glaucoma patients in Sweden.", "datePublished": "2022-06-24", "url": "https://questionsmedicales.fr/article/35750795", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-14962-9" } }, { "@type": "ScholarlyArticle", "name": "Fuzzy clustering of 24-2 visual field patterns can detect glaucoma progression.", "datePublished": "2024-09-04", "url": "https://questionsmedicales.fr/article/39231172", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0309011" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Disciplines et activités comportementales", "item": "https://questionsmedicales.fr/mesh/D004191" }, { "@type": "ListItem", "position": 3, "name": "Psychothérapie", "item": "https://questionsmedicales.fr/mesh/D011613" }, { "@type": "ListItem", "position": 4, "name": "Thérapie comportementale", "item": "https://questionsmedicales.fr/mesh/D001521" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Thérapie comportementale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Thérapie comportementale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Thérapie comportementale", "description": "Comment diagnostiquer un besoin de thérapie comportementale ?\nQuels tests sont utilisés pour le diagnostic ?\nQui peut poser un diagnostic pour cette thérapie ?\nQuels critères sont utilisés pour le diagnostic ?\nLa thérapie comportementale est-elle adaptée à tous ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Thérapie comportementale", "description": "Quels symptômes indiquent un besoin de thérapie comportementale ?\nComment les symptômes varient-ils selon les individus ?\nLes symptômes physiques sont-ils liés à la thérapie comportementale ?\nLes symptômes peuvent-ils s'aggraver sans traitement ?\nQuels sont les signes d'amélioration avec la thérapie ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Thérapie comportementale", "description": "Comment prévenir les troubles nécessitant une thérapie comportementale ?\nLes programmes scolaires peuvent-ils aider à la prévention ?\nQuels rôles jouent les parents dans la prévention ?\nLa prévention est-elle possible à l'âge adulte ?\nLes groupes de soutien peuvent-ils aider à la prévention ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Thérapie comportementale", "description": "Quelles techniques sont utilisées en thérapie comportementale ?\nCombien de séances sont généralement nécessaires ?\nLa thérapie comportementale peut-elle être combinée avec d'autres traitements ?\nQuels sont les objectifs principaux de cette thérapie ?\nLa thérapie comportementale est-elle efficace pour les enfants ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Thérapie comportementale", "description": "Quelles complications peuvent survenir sans traitement ?\nLa thérapie comportementale peut-elle entraîner des effets secondaires ?\nQuels risques de rechute existent après la thérapie ?\nLes complications psychologiques peuvent-elles affecter la santé physique ?\nComment minimiser les complications après la thérapie ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Thérapie comportementale", "description": "Quels facteurs augmentent le risque de troubles comportementaux ?\nL'environnement familial influence-t-il les comportements ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe manque de soutien social est-il un facteur de risque ?\nLes événements de vie stressants augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un besoin de thérapie comportementale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un professionnel évalue les comportements problématiques et leur impact sur la vie quotidienne." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires et des entretiens cliniques sont souvent utilisés pour évaluer les comportements." } }, { "@type": "Question", "name": "Qui peut poser un diagnostic pour cette thérapie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un psychologue, un psychiatre ou un thérapeute qualifié peut poser ce diagnostic." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent la fréquence, l'intensité et l'impact des comportements sur la vie." } }, { "@type": "Question", "name": "La thérapie comportementale est-elle adaptée à tous ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle est efficace pour de nombreux troubles, mais un diagnostic précis est essentiel." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin de thérapie comportementale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements compulsifs, des phobies ou des troubles d'anxiété peuvent indiquer ce besoin." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon les individus ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent varier en intensité et en type selon les expériences personnelles." } }, { "@type": "Question", "name": "Les symptômes physiques sont-ils liés à la thérapie comportementale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes physiques comme des palpitations peuvent accompagner des troubles psychologiques." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver sans traitement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement, les symptômes peuvent s'intensifier et affecter la qualité de vie." } }, { "@type": "Question", "name": "Quels sont les signes d'amélioration avec la thérapie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une réduction des comportements problématiques et une meilleure gestion des émotions sont des signes." } }, { "@type": "Question", "name": "Comment prévenir les troubles nécessitant une thérapie comportementale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par l'éducation émotionnelle et le développement de compétences sociales dès le jeune âge." } }, { "@type": "Question", "name": "Les programmes scolaires peuvent-ils aider à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des programmes de sensibilisation et de gestion des émotions dans les écoles peuvent être bénéfiques." } }, { "@type": "Question", "name": "Quels rôles jouent les parents dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les parents peuvent enseigner des stratégies de gestion du stress et des comportements positifs à leurs enfants." } }, { "@type": "Question", "name": "La prévention est-elle possible à l'âge adulte ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques de gestion du stress et de résolution de problèmes peuvent prévenir l'apparition de troubles." } }, { "@type": "Question", "name": "Les groupes de soutien peuvent-ils aider à la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les groupes de soutien offrent un espace pour partager des expériences et apprendre des stratégies de prévention." } }, { "@type": "Question", "name": "Quelles techniques sont utilisées en thérapie comportementale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme le conditionnement opérant, l'exposition et la restructuration cognitive sont courantes." } }, { "@type": "Question", "name": "Combien de séances sont généralement nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le nombre de séances varie, mais 10 à 20 séances sont souvent recommandées pour des résultats significatifs." } }, { "@type": "Question", "name": "La thérapie comportementale peut-elle être combinée avec d'autres traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent combinée avec des médicaments ou d'autres formes de thérapie pour une efficacité accrue." } }, { "@type": "Question", "name": "Quels sont les objectifs principaux de cette thérapie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les objectifs incluent la modification des comportements inadaptés et l'amélioration des compétences d'adaptation." } }, { "@type": "Question", "name": "La thérapie comportementale est-elle efficace pour les enfants ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent utilisée pour traiter des troubles chez les enfants, comme l'anxiété et les phobies." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans traitement ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Sans traitement, les troubles peuvent s'aggraver, entraînant des problèmes relationnels et professionnels." } }, { "@type": "Question", "name": "La thérapie comportementale peut-elle entraîner des effets secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Généralement, elle n'a pas d'effets secondaires physiques, mais des émotions intenses peuvent survenir." } }, { "@type": "Question", "name": "Quels risques de rechute existent après la thérapie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des rechutes peuvent survenir si les compétences acquises ne sont pas pratiquées régulièrement." } }, { "@type": "Question", "name": "Les complications psychologiques peuvent-elles affecter la santé physique ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles psychologiques non traités peuvent entraîner des problèmes de santé physique, comme des maladies cardiaques." } }, { "@type": "Question", "name": "Comment minimiser les complications après la thérapie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La pratique continue des compétences apprises et le soutien social aident à minimiser les complications." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de troubles comportementaux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme le stress, l'hérédité et des événements traumatiques augmentent le risque." } }, { "@type": "Question", "name": "L'environnement familial influence-t-il les comportements ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un environnement familial instable ou conflictuel peut contribuer au développement de troubles." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de troubles mentaux dans la famille peuvent augmenter le risque de troubles comportementaux." } }, { "@type": "Question", "name": "Le manque de soutien social est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un manque de soutien social peut exacerber les troubles et rendre la gestion plus difficile." } }, { "@type": "Question", "name": "Les événements de vie stressants augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des événements comme un divorce ou la perte d'un emploi peuvent déclencher des troubles comportementaux." } } ] } ] }

Sous-catégories

16 au total

Sources (10000 au total)

Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma.

Faster worsening of 10-2 visual field (VF) was associated with the development of visual acuity (VA) loss in mild-to-moderate glaucoma, suggesting longitudinal 10-2 VF change is associated with the ri... To examine whether longitudinal 10-2 central VF change is associated with the risk of VA loss in glaucoma.... Primary open angle glaucoma and glaucoma suspect eyes with ≥3 years and 5 visits of 10-2 VF examinations were included. Cox proportional hazard modeling with shared frailty was used to evaluate the ha... Among the 252 eyes (148 participants, mean follow-up = 5.8 y), 30 eyes (21 participants, mean follow-up = 4.9 y) developed VA loss. There was no difference in baseline VF between eyes with and without... Faster 10-2 VF MD and hemifield MS worsening are associated with the development of VA loss. Monitoring the longitudinal central 10-degree VF change may suggest that there is impending VA impairment i...

Fuzzy clustering of 24-2 visual field patterns can detect glaucoma progression.

To represent 24-2 visual field (VF) losses of individual patients using a hybrid approach of archetypal analysis (AA) and fuzzy c-means (FCM) clustering.... In this multicenter retrospective study, we classified characteristic patterns of 24-2 VF using AA and decomposed them with FCM clustering. We predicted the change in mean deviation (MD) through super... We identified 16 characteristic patterns (archetypes or ATs) of 24-2 VF from 132,938 VFs of 18,033 participants using AA. The hybrid approach using FCM revealed a lower mean squared error and greater ... A hybrid approach combining AA and FCM to analyze 24-2 VF can visualize VF tests in characteristic patterns and enhance detection of VF progression with lossless decomposition....

Predicting Visual Field Progression by Optical Coherence Tomography Angiography and Pattern Electroretinography in Glaucoma.

Reduced P50-N95 amplitude on pattern electroretinography (PERG) and the presence of microvasculature dropout (MvD) on optical coherence tomography angiography (OCT-A) at baseline were significant fact... We investigated the baseline demographics and ocular characteristics that predict future progression in glaucoma patients, including PERG and OCT-A parameters.... One Hundred forty eyes with open angle glaucoma that were prospectively enrolled and followed up for at least 3 years, and underwent at least 5 serial VF tests were included. Baseline PERG was perform... Of the 140 eyes, 107 (76.4%) were NTG and 57 (40.7%) exhibited glaucoma progression as defined by Humphrey VF GPA. The MD slopes were -0.43±1.11 dB/y in the progressors and 0.59±1.27 dB/y in the nonpr... The presence of MvD and retinal ganglion cell dysfunction by PERG at baseline, DH or central scotoma were significant factors associated with VF progression in predominantly NTG patients. These patien...

Visual field indices in children and adults with comparable retinal nerve fiber layer thickness.

To compare visual field indices in normal children and adults with similar retinal nerve fiber layer (RNFL) thickness on optical coherence tomography (OCT).... This cross-sectional study included 59 eyes of 59 normal children 6-18 years of age compared to normal adults. The children underwent visual field testing on the Humphrey Field Analyzer (HFA) and RNFL... Overall, the MD of children was significantly less than that of the normal adults despite having the same RNFL thickness (-2.42 ± 1.42 dB vs -1.61 ± 1.47 dB [P = 0.006]). When stratified by age, the d... In our study cohort, children <12 years had lower visual field indices than adults. Their visual fields may appear worse than they would for an adult with the same RNFL thickness. Normal children >12 ...

Predicting Visual Field Worsening with Longitudinal OCT Data Using a Gated Transformer Network.

To identify visual field (VF) worsening from longitudinal OCT data using a gated transformer network (GTN) and to examine how GTN performance varies for different definitions of VF worsening and diffe... Retrospective longitudinal cohort study.... A total of 4211 eyes (2666 patients) followed up at the Johns Hopkins Wilmer Eye Institute with at least 5 reliable VF results and 1 reliable OCT scan within 1 year of each reliable VF test.... For each eye, we used 3 trend-based methods (mean deviation [MD] slope, VF index slope, and pointwise linear regression) and 3 event-based methods (Guided Progression Analysis, Collaborative Initial G... Area under the receiver operating characteristic curve (AUC).... The M6 labeled 63 eyes (1.50%) as worsening. The GTN achieved an AUC of 0.97 (95% confidence interval, 0.88-1.00) when trained with M6. Gated transformer networks trained and optimized with the other ... Gated transformer network models trained with OCT data may be used to identify VF worsening. After further validation, implementing such models in clinical practice may allow us to track functional wo... Proprietary or commercial disclosure may be found after the references....